Bristol-Myers introduced CEENUᆴ (lomustine), a chemotherapy product for brain cancer and Hodgkins lymphoma
In 1976, Bristol-Myers introduced CEENUᆴ (lomustine), a chemotherapy product for brain cancer and Hodgkins lymphoma.
Tags:
Source: Bristol-Myers Squibb Company
Credit: